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Abstract
Background: The	 heart	 rate	 variability‐derived	 Newborn	 Infant	 Parasympathetic	
Evaluation	(NIPE™)	Index	is	a	continuous	noninvasive	tool	to	assess	pain	and	discom‐
fort	in	infants	<2	years.	Initial	studies	focused	on	pain	monitoring	in	the	neonatal	in‐
tensive	care	unit	environment.
Aims: The	aim	of	this	study	was	to	investigate	the	performance	of	the	NIPE	in	infants	
under	sevoflurane	anesthesia.	The	primary	objective	of	this	study	was	to	compare	
the	NIPE	 and	heart	 rate	 as	 tools	 to	 help	 recognize	 the	need	 for	 additional	 opioid	
drugs.	Secondary	objectives	were	the	course	of	the	NIPE	and	heart	rate	around	spe‐
cific	standardized	noxious	procedural	mile‐stones.
Methods: NIPE	and	heart	rate	values	recorded	during	a	120	seconds	interval	before	
the	anesthetist's	decision	to	administer	additional	opioid	due	to	the	perceived	insuf‐
ficient	antinociception	and	during	a	120	seconds	interval	after	drug	administration	
were	analyzed	by	means	of	a	repeated	measures	ANOVA.	The	same	analyses	were	
performed	for	datasets	around	per	protocol	administration	of	morphine	for	postop‐
erative	analgesia,	performance	of	a	caudal	block	and	surgical	incision.
Results: In	patients	with	a	NIPE	value	<50,	an	additional	opioid	drug	administration	
resulted	 in	 a	 rise	 of	 NIPE	 values,	 reaching	 a	 maximum	 increase	 of	 5.1	 (95%	 CI:	
0.22‐9.99)	units	120	seconds	after	drug	administration	(P	=	0.041).	There	was	no	evi‐
dence	of	a	change	in	heart	rate	during	these	two	120	seconds	periods.	Per	protocol	
administration	 of	 morphine,	 caudal	 block,	 and	 surgical	 incision	 did	 not	 result	 in	
changes	of	the	NIPE,	which	was	around	65	units	on	these	occasions,	and	heart	rate.
Conclusion: In	 infants	 anesthetized	 with	 sevoflurane,	 NIPE	 values	 <50	 might	 be	
indicative	of	insufficient	antinociception.	The	results	of	this	observational	pilot	study	
might	suggest	that	the	NIPE	could	be	a	better	measure	of	the	nociception/antinocic‐
eption balance than heart rate.
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1  | INTRODUC TION
The	assessment	of	the	nociception/antinociception	balance	in	an‐
esthetized	patients	is	often	performed	by	using	surrogate	param‐
eters,	such	as	heart	rate	and	blood	pressure,	together	with	other	
clinical	signs	such	as	sweating	or	movement.	These	parameters	are	
known	to	have	 low	sensitivity	and	specificity	 in	detecting	 inade‐
quate	 antinociception,	 possibly	 resulting	 in	 under‐	 or	 overdosing	
of	opioid	drugs.1	 The	 clinical	 impression	of	 an	 anesthetist	 surely	
remains	 the	 most	 frequently	 applied	 heuristic	 approach	 to	 help	
decide	whether	 or	 not	 an	 anesthetized	 patient	 needs	 additional	
opioids.
Several	 analgesia	monitoring	 systems,	 aiming	 to	achieve	con‐
tinuous,	 objective,	 and	 nondisruptive	 detection	 of	 analgesia	 or	
assessment	 of	 the	 nociception/antinociception	 balance	 have	 re‐
cently	become	commercially	available.	These	devices	use	surrogate	
parameters	 of	 nociception,	 such	 as	 processed	 skin	 conductance,	
plethysmography,	 pupillometry,	 and	 heart	 rate	 variability	 (HRV)	
analysis.2
Recent	 studies	 performed	 in	 anesthetized	 children	 sug‐
gest	 that	 the	 heart	 rate	 variability	 analysis	 derived	 Analgesia	
Nociception	 Index	 (ANI™;	 Mdoloris	 Medical	 Systems,	 Loos,	
France)	may	provide	a	more	sensitive	assessment	of	the	nocicep‐
tion/antinociception	 balance	 than	 hemodynamic	 parameters.3‐5 
These	pediatric	studies	are	in	accordance	with	the	results	of	stud‐
ies	investigating	the	performance	of	the	ANI	in	anesthetized	adult	
patients.6‐8
The	ANI	was	developed	for	HRV	analysis	in	adults	and	children	
older	 than	2	years.	Neonates	 and	 infants	 (<2	years),	 due	 to	 imma‐
turity	of	the	autonomous	nervous	system	and	a	higher	baseline	HR	
resulting	in	a	lower	possible	variability,	require	a	modified	approach	
to	HRV	 analysis.	 The	Newborn	 Infant	 Parasympathetic	 Evaluation	
(NIPE,	Mdoloris	Medical	Systems)	 Index,	a	modified	version	of	the	
ANI,	was	developed	for	use	in	neonates	(including	premature	infants)	
and	infants	up	to	2	years	of	age.9	While	there	is	a	growing	body	of	
evidence	showing	the	ability	of	the	ANI	to	provide	valid	information	
regarding	 the	 nociception/antinociception	 balance	 in	 anesthetized	
children,	little	is	known	about	the	performance	of	the	NIPE	in	anes‐
thetized	neonates	and	infants.
The	 primary	 objective	 of	 this	 prospective	 observational	
pilot	study	 in	surgical	neonates	and	 infants	under	sevoflurane	
anesthesia,	was	to	investigate	the	ability	of	the	NIPE	and	heart	
rate	 to	 detect	 an	 insufficient	 antinociception.	 Major	 second‐
ary	objectives	were	 the	 impact	 of	 per	 protocol	 opioid	 admin‐
istration	for	postoperative	analgesia,	caudal	analgesia,	and	the	
surgical	 incision	 on	 the	 course	 of	 the	NIPE.	 Changes	 in	NIPE	
values	were	compared	to	concomitant	changes	in	heart	rate	for	
all	analyses.
2  | MATERIAL S AND METHODS
2.1 | Patient selection
This	 single	 center	 prospective	 observational	 pilot	 study	 was	 ap‐
proved	by	the	Medical	Ethics	Committee	of	the	Erasmus	University	
Medical	 Center,	 Rotterdam,	 The	 Netherlands	 (MEC‐2016‐501;	
August	 9,	 2016)	 and	 was	 conducted	 in	 accordance	 with	 the	
Declaration	of	the	World	Medical	Association.	The	written	informed	
consent	was	obtained	 for	 all	 participating	patients	 from	 their	 par‐
ents	or	 legal	 representatives.	The	study	was	conducted	 in	accord‐
ance	with	the	STROBE	guidelines10	between	March	and	June	2017.
Pediatric	 patients	 aged	0‐2	years,	 scheduled	 for	 surgical	 or	 di‐
agnostic	 procedures	 under	 sevoflurane	 anesthesia,	 performed	 at	
the	Erasmus	University	Medical	Center—Sophia	Children's	Hospital,	
Rotterdam,	The	Netherlands,	were	eligible	for	inclusion.	According	
to	 departmental	 standards	 patients	 received	 intravenous	 parac‐
etamol	20	mg/kg	and	diclofenac	1	mg/kg	 (only	 infants	>6	months)	
during	the	procedure	for	postoperative	analgesia.	Depending	on	the	
surgical	 procedure	 patients	 furthermore	 received	 either	 a	 caudal	
block	(ropivacaine	0.2%,	1‐1.25	mL/kg)	or	iv	morphine	(0.1	mg/kg).
Due	 to	 technical	 requirements	 of	 the	NIPE	 algorithm	 any	 car‐
diac	 rhythm	other	 than	 sinus	 rhythm,	presence	of	 an	 internal	 car‐
diac	pacemaker,	high‐frequency	oscillation‐	or	jet‐ventilation	during	
surgery,	and	chronic	use	of	medication	interfering	with	the	cardiac	
rhythm	were	 defined	 as	 primary	 exclusion	 criteria.	 Intraoperative	
need	for	clonidine,	atropine	or	inotropes,	and	vasopressors	resulted	
in	secondary	exclusion.
2.2 | The Newborn Infant Parasympathetic 
Evaluation Index
The	heart	rate	variability‐derived	Newborn	Infant	Parasympathetic	
Evaluation	 Index	 (NIPE)	 is	 calculated	 by	 using	 the	 ECG	 signal	
K E Y W O R D S
general	anesthesia,	infant,	monitors,	pain
What is already known
•	 Processed	heart	rate	variability	is	a	sensitive	measure	of	
insufficient	 antinociception	 in	 anesthetized	 adult	 pa‐
tients	 and	 children	>2	years.	Data	 regarding	 its	 perfor‐
mance	in	anesthetized	neonates	and	infants	are	lacking.
What this article adds
•	 The	 heart	 rate	 variability‐derived	 Newborn	 Infant	
Parasympathetic	 Evaluation	 (NIPE™)	 Index	might	 be	 a	
more	 reliable	measure	of	 the	nociception/antinocicep‐
tion	balance	in	anesthetized	infants	than	heart	rate.
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recorded	 by	 and	 extracted	 from	 the	 standard	 anesthesia	 patient	
monitoring	system	(Dräger	Infinity®,	Drägerwerk	AG	&	Co.	KGaA,	
Lübeck,	Germany),	without	the	need	for	additional	ECG	electrodes.
The	basic	principle	of	the	NIPE	is	the	real‐time	analysis	of	the	para‐
sympathetic	 (pS)	 activity	 of	 the	 autonomous	 nervous	 system	 using	
heart	rate	variability	(HRV)	analysis.	HRV‐signals	>0.15	Hz	are	high	pass	
filtered,	enabling	an	automated	HRV	analysis	of	data	representative	of	
parasympathetic	activity,	expressing	the	physiological	respiratory	sinus	
arrhythmia.9	This	automated	analysis	results	in	a	dimensionless	numer‐
ical	value,	called	the	NIPE.	The	NIPE	ranges	from	0	to	100	and	reflects	
relative	pS	activity,	with	high	index	values	indicating	a	high	level	of	pS	
activity	and	vice	versa.	According	to	the	manufacturer,	NIPE	values	<50	
are	indicative	of	either	discomfort,	stress,	or	pain.11
An	in	depth	description	of	the	NIPE	methodology	and	the	devel‐
opment	of	the	algorithm	has	been	published	by	Butruille	et	al.9 The 
NIPE	serves	as	a	surrogate	parameter	of	the	nociception/antinoci‐
ception	balance	in	unconscious	neonates	and	infants	younger	than	
2	years,	in	conscious	patients	it	also	reflects	comfort	and	psycholog‐
ical	well‐being	or	discomfort	and	psychological	stress.
The	 NIPE‐monitor	 calculates	 two	 types	 of	 NIPE	 indices:	 The	
NIPEm	is	computed	as	a	mean	value	over	20	minutes,	whereas	the	in‐
stantaneous	NIPEi	provides	infromation	regarding	short‐term	HRV‐
analysis,	displayed	as	the	result	of	a	64	seconds	moving	window	with	
an	update	frequency	of	1	per	second.12	In	this	study,	designed	to	in‐
vestigate	acute	changes	of	the	nociception/antinociception	balance	
during	surgery,	we	only	used	the	NIPEi;	for	simplicity's	sake,	in	this	
paper	we	refer	to	it	as	the	NIPE.
2.3 | Intraoperative collection of study data
NIPE‐	 and	 heart	 rate	 data,	 recorded	 during	 the	 anesthetic,	 were	
downloaded	from	the	NIPE‐monitor	as	.txt‐files.	Data	derived	from	
our	Dräger	Infinity	patient	monitoring	system	were	exported	as	.xls	
files.	Only	data	 recorded	during	 the	surgery	were	used	 for	 subse‐
quent	analysis.
The	pediatric	anesthetist	in	charge	was	blinded	to	the	screen	of	
the	NIPE	monitor	and	the	conduct	of	the	anesthetic	was	totally	un‐
restricted.	Each	decision	 to	give	an	opioid	analgesic,	 for	whatever	
reason,	was	announced	to	a	researcher	who	recorded	this	decision	
and	the	subsequent	drug	administration.
2.4 | Statistical analysis
Analyses	were	 performed	 using	 data	 timely	 related	 to	 predefined	
events.	An	event	was	defined	as	 the	 intraoperative	administration	
of	opioid	drugs,	either	due	to	the	clinical	judgement	of	insufficient	
antinociception	 or	 per‐protocol	 administration	 for	 postoperative	
analgesia.
Repeated	 measures	 (RM)	 one‐way	 ANOVA	 with	 subsequent	
Dunnett's	multiple	comparisons	test	was	performed	to	investigate	
the	course	of	NIPE	and	HR‐values;	for	the	primary	objective	of	the	
study	during	a	120	seconds	period	both	before	 the	clinical	 judge‐
ment	 of	 insufficient	 antinociception	 and	 after	 subsequent	 opioid	
drug	 application.	 Additionally,	 a	 Wilcoxon	 matched‐pairs	 signed	
rank	test,	comparing	the	lowest	NIPE	values	(along	with	associated	
HR	values)	during	the	120	seconds	predecision	period	to	the	NIPE/
HR	values	120	seconds	after	opioid	drug	application	was	performed.
Both	ANOVA	and	the	Wilcoxon	matched‐pairs	signed	rank	test	
were	performed	separately	for	cases	when	the	NIPE	was	either	<50	
(DecisionNIPE	<50)	or	≥50	(DecisionNIPE	≥50)	at	the	time	of	decision	to	
administer	additional	opioid	analgesia.
For	the	secondary	objectives,	ANOVA	was	performed	to	investi‐
gate	the	impact	of	per‐protocol	application	of	morphine	for	postop‐
erative	analgesia	the	effect	of	caudal	epidural	analgesia	and	surgical	
incision	on	the	NIPE.
Unfortunately,	we	had	no	scientifically	sound	data	available	on	
which	we	could	have	based	a	valid	sample	size	calculation.	We	as‐
sumed	that	data	from	at	least	50	patients	should	provide	us	with	suf‐
ficient	information	to	further	develop	our	research	efforts	regarding	
monitoring	of	 the	nociception/antinociception	balance	 in	anesthe‐
tized	infants.	The	duration	of	the	project	was	set	to	3	months,	which	
based	on	our	 average	annual	number	of	 anesthetics	performed	 in	
children	younger	 than	2	years,	 should	be	sufficient	 to	 include	≥50	
participants.
Data	analysis	was	performed	using	Prism	7	for	Mac	OS	X	(Version	
7.0e,	GraphPad	Software	 Inc,	 La	 Jolla,	CA).	Continuous	data	were	
presented	as	mean	(SD).	P	values	<0.05	were	considered	significant.
3  | RESULTS
3.1 | Participant demographics and general patient 
information
A	 total	 of	 74	patients	 (female/male:	 20/54)	was	 recruited	 for	 par‐
ticipation,	of	which	7	patients	had	to	be	excluded	from	data	analysis	
due	 to	 the	permanent	data	 logging	 failure.	Age	and	weight	of	 the	
remaining	67	patients	were	36.7	±	21.5	weeks	 (postnatal	 age)	 and	
8.03	±	2.34	kg,	respectively.	Information	regarding	the	surgical	pro‐
cedures	and	anesthesia	techniques	are	given	in	Table	1.
TA B L E  1  Distribution	of	surgical	procedures	performed,	
together	with	anesthesia	technique
Type of surgery
Anesthesia technique
General 
anesthesia
Anesthesia with 
caudal block
Ear	nose	&	throat	surgery 3  
Ophthalmological	surgery 5  
General	pediatric	surgery 8 10
Neurosurgery 15  
Oral	&	maxillofacial	surgery 9  
Orthopedic	surgery 1 1
Plastic	surgery 1 1
Urological	surgery  13
Data	are	presented	as	total	numbers.
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A	 total	 of	 54	 events	 (intraoperative	 opioid	 drug	 administra‐
tion)	 was	 recorded,	 of	 which	 14	 had	 to	 be	 excluded	 from	 anal‐
ysis	 due	 to	 incidental	 data	 logging	 errors.	 Another	 25	 datasets	
describing	the	course	of	the	NIPE	in	patients	receiving	caudal	an‐
algesia	were	recorded,	of	which	4	had	to	be	excluded	from	anal‐
ysis	due	to	incidental	data	logging	errors.	Incidental	data	logging	
errors	were	mainly	due	to	missing	data	when	surgical	diathermy	
was	applied.	Complete	datasets	of	the	course	of	the	NIPE	and	HR	
around	the	time	of	surgical	incision,	recorded	in	patients	who	had	
not	received	regional	anesthesia	were	available	for	analysis	in	35	
patients.
3.2 | Course of NIPE and HR values around 
opioid administration due to perceived insufficient 
antinociception
Data	from	10	events	recorded	in	patients	with	NIPE	values	<50	at	
the	 time	 of	 decision	 (DecisionNIPE	 <50),	were	 available	 for	 analysis.	
RM‐ANOVA	 revealed	 no	 evidence	 of	 a	 difference	 between	NIPE‐
values	at	the	time	of	decision	to	give	opioid	drugs	due	to	a	perceived	
need	 for	 additional	 opioid	drug	 analgesia	 and	NIPE‐values	30,	60,	
90,	and	120	seconds	before.	The	reasons	to	give	additional	opioid	
drugs	were	either	a	perceived	rise	in	heart	rate,	patient	movement	
or	the	subjective	impression	of	the	anesthetist.	Due	to	the	relatively	
low	number	of	total	events	we	were	unable	to	perform	a	meaningful	
subgroup	analysis	as	to	the	reason	to	give	additional	opioid	drugs.	
We	found	evidence	of	an	 increase	 in	NIPE	values	90	and	120	sec‐
onds	 after	 drug	 administration	 (fentanyl	 1.6	±	0.6	µg/kg	 [n	=	25],	
sufentanil	 0.2	µg/kg	 [n	=	5],	 or	 increasing	 remifentanil	 infusion	 at	
the	discretion	of	the	anesthetist	[n	=	10])	compared	to	the	moment	
of	the	intervention	and	a	weak	evidence	of	such	a	difference	60	sec‐
onds	after	drug	administration.	There	was	no	evidence	of	a	change	in	
heart	rate	during	the	entire	period	(before	decision:	P	=	0.165;	after	
opioid	administration:	P	=	0.063).	Data	from	30	events	recorded	in	
patients	with	NIPE	values	≥50	at	the	time	of	decision	(DecisionNIPE	≥50),	
showed	stable	NIPE‐	and	HR	values	during	the	entire	period	before	
and	 after	 opioid	drug	 administration.	 For	 details	 see	Figure	1	 and	
Table 2.
A	Wilcoxon	matched‐pairs	signed	rank	test	comparing	the	low‐
est	NIPE/HR	values	during	a	120	seconds.	period	prior	 to	opiod	
drug	administration	to	NIPE/HR	120	seconds	after	opiod	admin‐
istration	showed	higher	NIPE	values	after	opioid	administration	in	
cases	with	predecision	values	<50	(n	=	16),	but	not	with	predeci‐
sion	values	≥50	(n	=	26).	We	found	no	evidence	of	a	difference	in	
heart	rate	before	and	after	opioid	drug	administration.	For	details	
see	Table	3.
F I G U R E  1  Course	of	the	Newborn	Infant	Parasympathetic	Evaluation	Index	(NIPE)	and	heart	rate	(HR)	before	and	after	iv	opioid	
drug	administration	associated	with	NIPE‐values	<50	(n	=	10)	and	≥	50	(n	=	30)	at	the	moment	of	decision	to	administer	opioids.	Data	are	
presented	as	mean	±	SD	[Colour	figure	can	be	viewed	at	wileyonlinelibrary.com]
P = P = P =
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3.3 | Course of NIPE and HR values around per 
protocol application of morphine
Data	from	nine	events	were	available	for	analysis.	RM‐ANOVA	re‐
vealed	no	evidence	of	 a	 difference	 in	NIPE	 and	HR	values	within	
both	120	seconds	windows	prior	to	decision	to	give	morphine	(NIPE:	
P	=	0.573;	HR:	P	=	0.709)	and	300	seconds	after	administration	of	
0.1	µg/kg	 morphine	 (NIPE:	 P	=	0.170;	 HR:	 P	=	0.183).	 The	 lowest	
and	highest	NIPE	values	after	morphine	application	were	55	±	12.4	
and	65	±	12.3,	respectively.	For	details	see	Figure	2	and	Table	2.
3.4 | Course of NIPE and HR values in patients with 
supplemental caudal block
Data	 from	 21	 patients	 were	 available	 for	 analysis.	 RM‐ANOVA	
revealed	 no	 evidence	 of	 a	 difference	 in	 NIPE	 and	 HR	 values	 in	
 Mean Diff. 95% CI of diff.
Adjusted 
P value
NIPE	<50	at	time	of	decision	(n	=	10)	[see	Figure	1]		  
Decision	vs	−120	s −8.1 −18.88	to	2.68 0.154
Decision	vs	−90	s −0.5 −13.02	to	12.02 0.999
Decision	vs	−60	s −5.8 −13.91	to	2.31 0.181
Decision	vs	−30	s −3.2 −7.23	to	0.82 0.127
Intervention	vs	+	30	s −1.1 −2.94	to	0.74 0.295
Intervention	vs	+	60	s −2.7 −2.94	to	0.75 0.051
Intervention	vs	+	90	s −3.6 −6.71	to	−0.49 0.025
Intervention	vs	+	120	s −5.1 −9.99	to	−0.22 0.041
NIPE	≥50	at	time	of	decision	(n	=	30)	[see	Figure	1]		  
Decision	vs	−120	s −4.1 −9.01	to	0.81 0.123
Decision	vs	−90	s −2.4 −6.86	to	2.06 0.451
Decision	vs	−60	s −1.3 −4.69	to	2.09 0.719
Decision	vs	−30	s −0.6 −3.85	to	2.72 0.976
Intervention	vs	+	30	s 1.6 −0.78	to	3.92 0.271
Intervention	vs	+	60	s 4.7 −1.09	to	10.56 0.137
Intervention	vs	+	90	s 4.2 −0.75	to	9.22 0.114
Intervention	vs	+	120	s 2.0 −3.44	to	7.37 0.753
NIPE	around	per	protocol	administration	of	morphine	(n	=	9)	[see	Figure	2]			
Intervention	vs	+	60	s 5.0 −8.1	to	18.1 0.656
Intervention	vs	+	120	s 3.8 −7.27	to	14.82 0.733
Intervention	vs	+	180	s 11.4 −1.78	to	24.67 0.092
Intervention	vs	+	240	s 3.9 −8.19	to	15.97 0.770
Intervention	vs	+	300	s 0.8 −11.57	to	13.13 0.10
NIPE	around	caudal	block	(n	=	21)	[see	Figure	3]	   
−30	sec	vs	block −0.3 −3.1	to	2.44 0.980
−30	sec	vs	block	+	30	s 3.6 −2.45	to	9.59 0.327
−30	sec	vs	block	+	60	s 3.8 −2.04	to	9.66 0.260
−30	sec	vs	Incision −1.5 −4.47	to	1.52 0.541
−30	sec	vs	Inc	+30	s 2.2 −3.12	to	7.56 0.681
−30	sec	vs	Inc	+60	s 4.1 −1.5	to	9.73 0.208
−30	sec	vs	Inc	+90	s 4.2 −2.23	to	10.61 0.291
−30	sec	vs	Inc	+120	s 4.67 −3.12	to	12.51 0.371
NIPE	around	surgical	incision	(n	=	35)    
−10	sec	vs	Incision 0.3 −0.93	to	1.61 0.895
−10	sec	vs	Inc	+10	s 0.8 −1.21	to	2.86 0.684
−10	sec	vs	Inc	+20	s 0.8 −1.28	to	2.82 0.738
−10	sec	vs	Inc	+30	s 1.49 −1.21	to	4.18 0.431
TA B L E  2  Repeated	measures	one‐way	
ANOVA	with	Dunnett's	multiple	
comparisons	test	comparing	NIPE	values	
over time
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response	to	the	application	of	the	caudal	block	(NIPE:	P	=	0.11;	HR:	
P	=	0.665)	and	surgical	incision,	which	was	allowed	after	a	minimum	
of	 10	min	 after	 caudal	 block	 (NIPE:	 P	=	0.05;	 HR:	 P	=	0.941);	 the	
lowest	and	highest	NIPE	values	within	this	dataset	were	65.4	±	17.4	
and	71.1	±	13.7,	respectively.	For	details	see	Figure	3	and	Table	2.
3.5 | Course of NIPE and HR values around 
surgical incision
Data	 from	 35	 patients	 (no	 supplemental	 regional	 anesthesia)	 were	
available	for	analysis.	RM‐ANOVA	revealed	no	evidence	of	a	difference	
in	NIPE	and	HR	values	in	response	to	surgical	incision	(NIPE:	P = 0.30; 
HR:	P	=	0.821);	the	lowest	and	highest	NIPE	values	within	this	dataset	
were	62.8	±	14.6	and	64.3	±	15.8,	respectively.	For	details	see	Table	2.
4  | DISCUSSION
The	results	of	this	observational	pilot	study	in	infants	younger	than	
2	years,	 anesthetized	 with	 sevoflurane,	 allow	 us	 to	 provisionally	
suggest	 the	 ability	 of	 the	NIPE	 to	 detect	 insufficient	 antinocicep‐
tion.	 This	 provisional	 conclusion	 is	 derived	 from	 the	 course	 of	 10	
events,	where	NIPE	values	<50	at	 the	 time	of	opioid	drug	 admin‐
istration	developed	positively	within	120	seconds	(see	Table	2	and	
Figure	1)	and	of	another	30	events,	where	NIPE	values	≥50	remained	
unchanged	 after	 opioid	 drug	 administration.	Heart	 rate	 showed	 a	
trend	toward	higher	values	prior	to	opioid	drug	administration	and	
lower	values	thereafter,	without	reaching	statistical	significance	(P	
preopioid	=	0.165;	P	postopioid	=	0.063).
In	our	study	surgical	incision	in	patients	who	had	a	caudal	block	
did	 not	 result	 in	 a	 rise	 of	 HR,	 any	 visible	 reaction	 or	 subsequent	
lower	NIPE	values.	From	a	clinical	perspective	we	were	able	to	con‐
clude	that	our	patients	had	sufficient	epidural	analgesia.	NIPE	values	
confirmed	this	clinical	impression.
Though	these	are	promising	findings,	any	conclusions	regarding	
the	performance	of	the	NIPE	as	a	monitor	of	the	nociception/antino‐
ciception	balance	in	anesthetized	infants	are	subject	to	restrictions,	
for	 the	 following	 reasons:	 The	 threshold	 of	 an	 index	 value	 of	 50	
indicating	either	sufficient	or	 insufficient	antinociception	has	been	
suggested	by	the	manufacturer	of	the	device;	its	plausibility	has	not	
yet	been	investigated	in	the	clinical	setting	of	pediatric	anesthesia.	
The	NIPE‐50‐threshold	 is	 an	 extrapolation	of	 the	50	units	 thresh‐
old	recommended	when	using	the	“adult	version”	of	the	device,	the	
Analgesia	Nociception	Index	(ANI),	with	a	growing	body	of	evidence	
suggesting	 sufficient	 antinociception	 associated	 with	 ANI	 values	
≥50,	while	values	<50	are	indicative	of	insufficient	antinociception.1 
F I G U R E  2  Course	of	the	Newborn	Infant	Parasympathetic	
Evaluation	Index	(NIPE)	and	heart	rate	(HR)	after	per‐protocol	
administration	of	iv	morphine	for	postoperative	analgesia;	(n	=	9).	
Data	are	presented	as	mean	±	SD	[Colour	figure	can	be	viewed	at	
wileyonlinelibrary.com]
F I G U R E  3  Course	of	the	Newborn	
Infant	Parasympathetic	Evaluation	Index	
(NIPE)	and	heart	rate	(HR)	before	and	
after	caudal	block	(left)	and	surgical	
incision	(right);	(n	=	21).	Data	are	
presented	as	mean	±	SD	[Colour	figure	
can	be	viewed	at	wileyonlinelibrary.com]
TA B L E  3  Wilcoxon	matched−pairs	signed	rank	test	comparing	
NIPE/Heart	rate	values	before	and	after	opioid	drug	application
 Median Diff. 95% CI of diff. P value
NIPE	<50	before	decision	(n	=	16)   
NIPE 11 6 to 22 <	0.001
Heart	rate 0 −3	to	2 0.692
NIPE	≥50	before	decision	(n	=	26)	   
NIPE −2.5 −17	to	6 0.167
Heart	rate −1.5 −4	to	0 0.094
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Though	NIPE	values	increased	statistically	significantly	after	opioid	
drug	administration	in	our	study,	the	magnitude	of	this	increase	was	
only	5	units	on	average,	reaching	a	mean	NIPE	of	no	more	than	45	
after	120	seconds.	It	remains	subject	to	speculation	whether	or	not	
this	is	a	clinically	relevant	difference.
This	and	other	findings	can	easily	be	compared	to	the	results	of	
our	recent	pediatric	study	with	the	ANI	monitor,	using	exactly	the	
same	 study	 design	 in	 patients	 aged	 between	 2	 and	 12	years.	 ANI	
values	<50	before	opioid	drug	administration	showed	a	significantly	
higher	increase	in	approximately	10	units	within	120	seconds,	trav‐
elling	across	the	50	units	border.5
In	 the	 current	 study,	 as	 in	 our	 aforementioned	 study	with	 the	
ANI,	NIPE	values	higher	than	±60	at	the	moment	of	opioid	drug	ad‐
ministration,	either	due	to	a	perceived	need	for	additional	analgesia	
or	per	protocol	administration	of	morphine	for	postoperative	anal‐
gesia,	remained	stable.	The	same	accounts	for	heart	rate.	However,	
we	are	still	lacking	independent	research	data	supporting	the	intra‐
operative	target	range	of	50‐70	suggested	by	the	device	manufac‐
turer.	Nevertheless,	these	data	could	be	a	first	indication	that	NIPE	
values	higher	than	60	might	be	indicative	of	sufficient	antinocicep‐
tion.	This	tentative	conclusion	by	no	means	suggests	a	NIPE	value	of	
60	as	a	threshold	value	to	make	a	distinction	between	sufficient	and	
insufficient	antinociception.
The	NIPE	was	 originally	 developed	 as	 an	 adaption	 of	 the	ANI	
technology	for	the	clinical	contexts	of	pain	monitoring	in	neonates	
on	the	neonatal	intensive	care	unit	and	the	maternity	unit,9 with a 
special	focus	on	prolonged	pain	assessment.12	Faye	et	al13 applied 
the	NIPE	algorithm	to	investigate	high	frequency	heart	rate	variabil‐
ity	(HRV)	as	an	indicator	of	prolonged	postoperative	pain	in	full‐term	
neonates	and	 found	an	association	between	pain	decreased	HRV,	
suggesting	HRV	as	a	measure	of	prolonged	pain	in	this	particular	pa‐
tient	group.	Cremillieux	et	al14	investigated	the	performance	of	the	
NIPE	as	an	objective	tool	for	acute	pain	assessment	in	29	preterm	
neonates	(mean	gestational	age	29.9	±	4.2	weeks)	and	found	no	cor‐
relation	between	the	NIPE	and	two	validated	clinical	pain	scales.	In	
the	present	study,	no	premature	infants	were	included.
In	conscious	subjects,	HRV	is	a	well‐established	measure	of	car‐
diac	 autonomic	 control,	 primarily	mediated	by	 the	 floating	 balance	
between	sympathetic	and	parasympathetic	tone.	From	a	clinical	point	
of	view,	HRV	can	be	regarded	as	a	surrogate	for	(dis‐)	comfort	and/or	
psychological	well‐being	or	stress.	Under	general	anesthesia	condi‐
tions,	with	patients	being	unconscious,	we	are	faced	with	a	completely	
different	scenario.	Comfort	and	pain,	both	expressions	of	conscious	
perception,	can	by	definition	not	be	applied	in	anesthetized	patients.	
This	is	not	just	a	semantical	question,	it	describes	a	significant	issue	
regarding	 the	 applicability	 of	 HRV‐derived	 devices	 as	 monitors	 of	
the	nociception/antinociception	balance	in	anesthetized	patients.	In	
accordance	with	 the	current	 scientific	 literature	we	assume	 that	 in	
patients	 anesthetized	with	 sufficient	 hypnotic	 drug	 concentrations	
to	assure	unconsciousness,	intraoperative	HRV	fluctuations	are	pri‐
marily	a	reflection	of	the	nociception/antinociception	balance.1	This	
assumption	is	the	all‐important	prerequisite	for	any	meaningful	study	
on	 the	 NIPE	 in	 surgical	 neonates	 and	 infants.	 Unfortunately,	 the	
aforementioned	assumption	has	never	been	proven	and	we	have	no	
idea	how	this	goal	could	ever	formally	be	reached.
Sevoflurane	 effect	 on	 baroreceptor	 reflex	 might	 be	 an	 issue	
when	using	HRV	derived	 technology	under	 anesthesia	 conditions.	
A	clinical	study	performed	in	adult	patients	showed	that	sevoflurane	
attenuates	 the	 baroreceptor	 reflex,	 which	 is	 known	 to	 contribute	
to heart rate variability.15	Kanaya	et	al16	found	little	to	no	effect	of	
sevoflurane	on	the	high	frequency	component	of	heart	rate	variabil‐
ity,	which	is	used	for	analysis	with	the	NIPE.
Heart	rate	variability	(HRV)	analysis	has	recently	gained	a	great	
deal	of	attention,	especially	in	neonatology	research.	HRV	is	signifi‐
cantly	positively	correlated	with	gestational	age,	like	blood	pressure,	
while	heart	 rate	shows	a	negative	correlation17;	 these	findings	are	
very	likely	related	to	the	degree	of	maturation	of	the	autonomic	ner‐
vous	system.18
4.1 | Shortcomings
We	did	not	use	blood	pressure	(BP)	values	as	surrogate	parameters	
of	the	nociception/antinociception	balance	in	our	study,	which	could	
be	regarded	as	a	shortcoming.	In	our	hospital,	noninvasive	BP	meas‐
urements,	performed	at	5	minutes	intervals	are	the	standard	of	care.	
It	would	make	no	sense	to	compare	a	single	BP	value	recorded	every	
5	minutes	to	a	NIPE‐	or	HR‐value	with	update	frequencies	of	1	per	
second.	Invasive	BP	registrations	with	a	continuous	recording	would	
be	an	interesting	parameter	to	investigate	in	relation	to	both	NIPE	
and	HR,	but	we	only	use	them	in	selected	high‐risk	patients	under‐
going	major	surgery.
There	may	be	some	criticism	regarding	the	120	seconds	observa‐
tion	window	after	opioid	drug	administration,	because	it	could	be	that	
120	seconds	is	too	short	a	period	of	time	for	the	opioid	drugs	delivered	
to	have	reached	their	peak	effect.	On	the	other	hand,	extending	that	
period	to	180	or	240	seconds	comes	with	an	increased	risk	of	signifi‐
cant	variation	in	surgical	noxious	stimulation.	However,	the	possibility	
remains	that	we	missed	some	opioid	drug	effect.
It	might	as	well	be	that,	at	least	in	some	patients,	the	amounts	of	
fentanyl/sufentanil/remifentanil	applied	were	 insufficient	 to	 re‐es‐
tablish	sufficient	antinociception.	Furthermore,	we	cannot	entirely	
rule	out	occasional	misjudgments	in	the	decision‐making	regarding	
the	need	for	additional	opioid	drugs;	 in	other	words:	there	was	no	
real	"proof"	of	insufficient	antinociception.
Due	to	the	design	of	this	strictly	observational	pilot	study,	there	
was	a	multitude	of	different	noxious	stimuli	influencing	the	nocicep‐
tion/antinociception	balance.	A	standardized	noxious	stimulus	and	
a	standardized	anesthetic	protocol	would	be	desirable,	but	requires	
an	intervention	study	design,	which	would	have	been	inappropriate	
to	perform	at	that	stage.
4.2 | Future directions
The	results	of	this	study	can	help	to	design	sufficiently	powered	future	
studies	investigating	the	performance	of	the	NIPE	in	anesthetized	in‐
fants.	A	reliable	NIPE	cut‐off	value	to	distinguish	between	sufficient	
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and	insufficient	antinociception	is	desirable,	though	we	are	aware	that	
this	will	be	a	major	methodological	challenge.	Furthermore,	future	NIPE	
studies	should	focus	on	dose‐response	relationships	of	intraoperative	
opioid‐drug	administration	in	neonates	and	infants.
5  | CONCLUSION
The	 results	of	 this	observational	 study	allow	 the	 following	careful	
first	 conclusions	 regarding	 the	 performance	 of	 the	 NIPE	 in	 term‐
neonates	 and	 infants	 anesthetized	 with	 sevoflurane:	 NIPE	 values	
<50	 might	 be	 indicative	 of	 insufficient	 antinociception.	 Whether	
or	 not	 an	 average	 rise	 of	 5	 NIPE	 units	 within	 120	seconds	 after	
opioid	 drug	 administration	 reflects	 re‐establishment	 of	 sufficient	
antinociception	remains	unclear.	A	rise	 in	NIPE	values	after	opioid	
drug	 administration	 is	 not	 necessarily	 associated	 with	 changes	 in	
heart	 rate.	Whether	 or	 not	 the	 finding	 that	 a	 rise	 in	NIPE	 values	
after	opioid	drug	administration	 is	not	necessarily	 associated	with	
changes	in	heart	rate	is	due	to	a	superiority	of	the	NIPE	over	heart	
rate	as	a	measure	of	the	nociception/antinociception	balance	needs	
to	be	addressed	in	future	clinical	studies.
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